The global Tardive Dyskinesia Therapeutics Market continues to evolve as healthcare providers increasingly recognize the importance of managing neurological complications associated with psychiatric medications. According to Polaris Market Research, the market is expected to grow from USD 3.98 billion in 2024 to USD 5.57 billion by 2032, registering a 4.3% CAGR during the forecast period....